Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol vs HCTZ in Hypertensive Patients with Impaired Glucose Tolerance
NCT00673790Phase 4Completed
- Sponsor
- Forest Laboratories
- Start
- May 2008
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nebivolol in hypertension (HTN), sponsored by Forest Laboratories. Started May 2008; status: completed.
02
Drugs
nebivolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00673790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00673790.